Hudson Acquisition I announces letter of intent for business combination

Hudson Acquisition I announced that it has entered into a letter of intent with a target company for a potential business combination. The LOI is not a binding agreement, and it outlines the preliminary terms of the Acquisition and the transactions contemplated herein. The Target Company is a pre-clinical-stage biotechnology company focused on developing intranasal preventives for major disease-causing respiratory viruses.